Peppermint Venture Partners leads Series A extension for CryoTherapeutics
CryoTherapeutics GmbH said Tuesday that it has completed an extension to its Series A financing, bringing the total tally to 6.5 million euros. Peppermint Venture Partners via its Charité Biomedical Fund led the round with participation from, KfW, NRW.BANK, Rainer Christine Asset Management GmbH, High-Tech Gründerfonds and Getz Brothers. Based in Germany, CryoTherapeutics is a producer of a cryotherapy system used to treat coronary artery disease.
6 May 2014•3 mins read
